alanine has been researched along with Adenoma, Prostatic in 14 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prazosin, a selective alpha 1-adrenoceptor blocker, was compared with Paraprost in a double-blind, multi-institutional study in patients with benign prostatic hyperplasia." | 5.06 | Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study. ( Aoki, H; Kobayashi, M; Ohinata, M; Ohori, M; Shiraiwa, Y; Tsuzuki, T; Yamaguchi, O; Yokota, T, 1990) |
| "A large proportion of benign prostatic hyperplasia (BPH) patients suffer from lower urinary tract symptoms after surgery due to the presence of prostatic urothelium wounds." | 1.56 | Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation via the NF-κB signaling pathway. ( Cui, X; Deng, Z; Han, B; Jiang, C; Jing, Y; Li, W; Shi, F; Sun, M; Xia, S; Xu, Z; Zhang, W; Zhou, Z, 2020) |
| "Seven patients were diagnosed with prostate cancer, 13 with benign prostatic hypertrophy, and 3 with both conditions." | 1.28 | Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR. ( Dalrymple, GV; Finkbeiner, AE; Fowler, AH; Holder, JC; Komoroski, RA; Mullins, MS; Pappas, AA; Sprigg, JR, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Xia, B | 1 |
| Zheng, H | 1 |
| Ning, J | 1 |
| Zhu, Y | 1 |
| Shao, X | 1 |
| Liu, B | 1 |
| Dong, B | 1 |
| Gao, H | 1 |
| Sun, M | 1 |
| Deng, Z | 1 |
| Shi, F | 1 |
| Zhou, Z | 1 |
| Jiang, C | 1 |
| Xu, Z | 1 |
| Cui, X | 1 |
| Li, W | 1 |
| Jing, Y | 1 |
| Han, B | 1 |
| Zhang, W | 1 |
| Xia, S | 1 |
| Okada, H | 1 |
| FEINBLATT, HM | 1 |
| GANT, JC | 1 |
| Giwercman, YL | 1 |
| Abrahamsson, PA | 1 |
| Giwercman, A | 1 |
| Gadaleanu, V | 1 |
| Ahlgren, G | 1 |
| Fowler, AH | 1 |
| Pappas, AA | 1 |
| Holder, JC | 1 |
| Finkbeiner, AE | 1 |
| Dalrymple, GV | 1 |
| Mullins, MS | 1 |
| Sprigg, JR | 1 |
| Komoroski, RA | 1 |
| Yamaguchi, O | 1 |
| Shiraiwa, Y | 1 |
| Kobayashi, M | 1 |
| Yokota, T | 1 |
| Ohinata, M | 1 |
| Aoki, H | 1 |
| Tsuzuki, T | 1 |
| Ohori, M | 1 |
| Maekawa, M | 1 |
| Kishimoto, T | 1 |
| Yasumoto, R | 1 |
| Wada, S | 1 |
| Harada, T | 1 |
| Ohara, T | 1 |
| Okajima, E | 1 |
| Hirao, Y | 1 |
| Ohzono, S | 1 |
| Shimada, K | 1 |
| Kumamoto, Y | 1 |
| Tsukamoto, T | 1 |
| Yachiku, S | 1 |
| Kaneko, S | 1 |
| Koyanagi, T | 1 |
| Togashi, M | 1 |
| Maru, A | 1 |
| Tsuchida, S | 1 |
| Nishizawa, O | 1 |
| Orikasa, S | 1 |
| Aito, K | 1 |
| Watsubo, E | 1 |
| Shiga, H | 1 |
| Kumamoto, E | 1 |
| Imamura, A | 1 |
| Ishigami, J | 1 |
| Kuroda, K | 1 |
| Sugiura, H | 2 |
| Shimaya, M | 2 |
1 review available for alanine and Adenoma, Prostatic
| Article | Year |
|---|---|
[BPH pharmacotherapy (miscellaneous)].
Topics: Alanine; Drug Combinations; Ethamsylate; Glutamates; Glycine; Humans; Male; Plant Extracts; Prostati | 2002 |
5 trials available for alanine and Adenoma, Prostatic
| Article | Year |
|---|---|
Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study.
Topics: Aged; Aged, 80 and over; Alanine; Double-Blind Method; Drug Combinations; Glutamates; Glycine; Human | 1990 |
[Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
Topics: Aged; Aged, 80 and over; Alanine; Chi-Square Distribution; Clinical Trials as Topic; Double-Blind Me | 1990 |
[A double-blind trial on the effect of bunazosin hydrochloride for the symptoms of benign prostatic hypertrophy].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Alanine; Chi-Square Distribution; Double-Blin | 1990 |
[Amino acid therapy for hypertrophy of the prostate].
Topics: Aged; Alanine; Clinical Trials as Topic; Glutamine; Glycine; Humans; Male; Middle Aged; Placebos; Pr | 1968 |
[Double blind test of PPC for prostatic hyperplasia].
Topics: Aged; Alanine; Amino Acids; Drug Synergism; Glutamates; Humans; Male; Middle Aged; Prostatic Hyperpl | 1970 |
8 other studies available for alanine and Adenoma, Prostatic
| Article | Year |
|---|---|
Identification of characteristic metabolic panels for different stages of prostate cancer by
Topics: Acetone; Alanine; Cross-Sectional Studies; Humans; Magnetic Resonance Spectroscopy; Male; Metabolomi | 2022 |
Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation via the NF-κB signaling pathway.
Topics: Alanine; Animals; Cell Proliferation; Chitosan; Dogs; Drug Compounding; Humans; Macrophages; Male; N | 2020 |
Palliative treatment of benign prostatic hypertrophy; value of glycine-alanine-glutamic acid combination.
Topics: Alanine; Dipeptides; Fabaceae; Glutamates; Glutamic Acid; Glycine; Humans; Hypertrophy; Male; Pallia | 1958 |
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Alanine; Alleles; Arginine; Biomarkers, Tumor; Case-Con | 2005 |
Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR.
Topics: Alanine; Citrates; Creatine; Glutamates; Glutamic Acid; Humans; In Vitro Techniques; Magnetic Resona | 1992 |
[The conservative treatment of prostatic hypertrophy with Paraprost].
Topics: Aged; Alanine; Drug Combinations; Glutamates; Glycine; Humans; Male; Middle Aged; Prostatic Hyperpla | 1972 |
[Clinical effect of PPC for the palliative treatment of benign prostatic hypertrophy].
Topics: Adult; Aged; Alanine; Glutamates; Glycine; Humans; Male; Middle Aged; Palliative Care; Prostatic Hyp | 1969 |
[Clinical application of "PPC" to prostatic hypertrophy and others].
Topics: Alanine; Capsules; Glutamates; Glycine; Humans; Male; Prostatic Diseases; Prostatic Hyperplasia; Pro | 1969 |